𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroleptic malignant syndrome

✍ Scribed by Tsong-Hai Lee; Lok-Ming Tang

Publisher
Springer
Year
1988
Tongue
English
Weight
417 KB
Volume
235
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroleptic malignant syndrome and catat
Neuroleptic malignant syndrome and catatonia
✍ Michele Raja; Maria Concetta Altavista; Stefano Cavallari; Loredana Lubich πŸ“‚ Article πŸ“… 1994 πŸ› Springer-Verlag 🌐 English βš– 611 KB
Neoplasia and the neuroleptic malignant
Neoplasia and the neuroleptic malignant syndrome
✍ P. W. R. Wooduff; E. Palazidou; I. Cranston; B. K. Toone; B. Summers; A. L. W. F πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 309 KB

## Abstract The association of neuroleptic malignant syndrome with neoplasia has not been previously reported. We report the case of a 64‐year‐old female patient who developed the classical picture of neuroleptic malignant syndrome in relation to a uterine leiomyosarcoma. This raises the question a

Clinical risk factors for neuroleptic ma
Clinical risk factors for neuroleptic malignant syndrome
✍ Domenico Berardi; Maddalena Dell'Atti; Mario Amore; Diana De Ronchi; Giuseppe Fe πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 50 KB

Pharmacological risk factors for neuroleptic malignant syndrome (NMS) are better defined than clinical risk factors. We examined the psychopathological status preceding the onset of NMS in 20 patients. We evaluated four key psychiatric symptoms (psychomotor agitation, catatonia, disorganization and

Treatment of neuroleptic malignant syndr
Treatment of neuroleptic malignant syndrome with levodopa
✍ K. Otani; K. Mihara; T. Kondo; M. Okada; S. Kaneko; Y. Fukushima πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 400 KB

Seven consecutive episodes of neuroleptic malignant syndrome in five cases were treated with 50-600 mg/day (mean 342 mg/day) of levodopa. In four episodes active pharmacological treatment was initiated with levodopa, while in the remaining three episodes it was introduced because of poor therapeutic